A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site
José G. Monzon, Hatim Karachiwala, John Walker, R. Goel et autres
0 citationsEuropean Journal of Cancer
John Walker
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
112Publications signalées
4155Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersMelanoma and MAPK PathwaysCutaneous Melanoma Detection and ManagementPolyomavirus and related diseasesCAR-T cell therapy research
Publications récentes
Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301)
Adi Diab, Paolo A. Ascierto, Michele Maio, Reham Abdel‐Wahab et autres
1 citationJournal of Clinical Oncology
Merkel cell carcinoma in a psoriasis patient on long-term ixekizumab therapy: A case report
S. R. K. Malik, Thomas G. Salopek, John Walker, Robert Gniadecki
1 citationSAGE Open Medical Case Reports
Advances in cancer therapy require urgent changes to the oncology workforce
Omar Abdel‐Rahman, Hyejee Ohm, Angela W. Chan, Shaun Loewen et autres
4 citationsCanadian Medical Association Journal
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301)
Adi Diab, Paolo A. Ascierto, Michele Maio, Reham Abdel‐Wahab et autres
10 citationsJournal of Clinical Oncology
Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events
Khashayar Esfahani, John Walker, Kevin Bambury, Eoin O’Carroll et autres
0 citationsCurrent Oncology
Assessing the effects of immune checkpoint inhibitors on bone utilizing machine learning–assisted opportunistic quantitative computed tomography
Bryn E. Matheson, Jacob L. Jaremko, Alexandra Dowhanik, Jasmine Gill et autres
7 citationsJournal of Bone and Mineral Research
Résultats du suivi à 10 ans de l’association nivolumab plus ipilimumab dans le mélanome avancé issus de l’essai de phase 3, CheckMate 067
James Larkin, Vanna Chiarion‐Sileni, Caroline Gaudy‐Marqueste, Piotr Rutkowski et autres
0 citationsAnnales de Dermatologie et de Vénéréologie - FMC
Sarcopenia etymology: Sarcos (flesh) penia (poverty) i.e. absence, lack or deficiency of a body constituent
Catherine Kubrak, Lisa Martin, Aaron J. Grossberg, Brennan Olson et autres
2 citationsClinical Nutrition
A multi-centre, single arm, phase 2 trial of pembrolizumab in treatment-naïve patients with carcinoma of unknown primary site.
Jose Gerard Monzon, Hatim Karachiwala, John Walker, Rakesh Goel et autres
0 citationsJournal of Clinical Oncology
Prospective real-world evidence for the use of immune-checkpoint inhibitors and BRAF-targeted therapy in advanced melanoma from a large Canadian cohort.
John Lenehan, D. Scott Ernst, Leah Young, Angel M. Cronin et autres
0 citationsJournal of Clinical Oncology
Elevated CK from immune checkpoint inhibitor- related hypophysitis: a case report
Jasmine Gill, John Walker, Carrie Ye
1 citationJournal of Chemotherapy
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.